SCHEMBL13906711

SCHEMBL13906711

COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCON1CCCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.79
RET P07949 3/20 0.79
PDGFRB P09619 2/20 0.79
PLK4 O00444 1/20 0.79
GAK O14976 1/20 0.79
EPHB6 O15197 1/20 0.79
RIPK2 O43353 1/20 0.79
ERN1 O75460 1/20 0.79
STK10 O94804 1/20 0.79
MAP4K4 O95819 1/20 0.79
CHEK2 O96017 1/20 0.79
ABL1 P00519 1/20 0.79
EGFR P00533 1/20 0.79
ERBB2 P04626 1/20 0.79
LCK P06239 1/20 0.79
FYN P06241 1/20 0.79
CSF1R P07333 1/20 0.79
YES1 P07947 1/20 0.79
LYN P07948 1/20 0.79
MET P08581 1/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cediranib SCHEMBL29368143 0.88 KDR (1.00) KDRRETPDGFRBPLK4GAK
Cediranib SCHEMBL29383181 0.88 KDR (1.00) KDRRETPDGFRBPLK4GAK
Cediranib SCHEMBL29351458 0.88 KDR (1.00) KDRRETPDGFRBPLK4GAK
Cediranib SCHEMBL63147 0.88 KDR (1.00) KDRRETPDGFRBPLK4GAK
SCHEMBL1685423 0.87 ABCB11 (1.00) KDRRETPDGFRBPLK4GAK
SCHEMBL13906694 0.86 KDR (0.60) KDRRETPDGFRBPLK4GAK
SCHEMBL22779588 0.86 KDR (0.75) KDRRETPDGFRBPLK4GAK
SCHEMBL15952729 0.85 KDR (0.73) KDRRETPDGFRBPLK4GAK
SCHEMBL13906735 0.85 KDR (0.59) KDRRETPDGFRBPLK4GAK
SCHEMBL665691 0.85 KDR (0.73) KDRRETPDGFRBPLK4GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009030224-A2 NOVEL QUINAZOLINE COMPOUNDS AND THE USE THEREOF FOR TREATING CANCEROUS DISEASES SCHEBO BIOTECH AG (DE) 2009-03-12 WO disclosed